Works matching DE "FINANCING of biotechnology industries"

Results: 68

Risikokapital in der Schweiz - eine institutionelle Analyse.

Published in:

Swiss Journal of Sociology / Schweizerische Zeitschrift für Soziologie, 2013, v. 39, n. 3, p. 465

By:

Passarge, Eva;
Hasse, Raimund

Publication type:

Article

Biotech Venture Capital Investments in Public Equities and Performance.

Published in:

Journal of Commercial Biotechnology, 2016, v. 22, n. 4, p. 39, doi. 10.5912/jcb758

By:

Jeppsson, Hans

Publication type:

Article

Debt and taxes: Marginal tax rate changes, capital structure, and innovative activity in the biotechnology sector.

Published in:

Journal of Commercial Biotechnology, 2015, v. 21, n. 1, p. 19, doi. 10.5912/jcb683

By:

Skrepnek, Grant H.

Publication type:

Article

Reverse stock splits in the biotechnology industry: An effectuation approach.

Published in:

Journal of Commercial Biotechnology, 2015, v. 21, n. 1, p. 3, doi. 10.5912/jcb677

By:

Wei Wu;
Couch, Robert;
Yulianto Suharto;
Ahn, Mark J.

Publication type:

Article

New technologies for neglected diseases: Can tax credits help biotechnology companies advance global health?

Published in:

Journal of Commercial Biotechnology, 2011, v. 17, n. 4, p. 290, doi. 10.1057/jcb.2011.27

By:

Rao, Aarthi

Publication type:

Article

Biotech entrepreneurs swoon over proposed fundraising changes.

Published in:

Nature Medicine, 2012, v. 18, n. 1, p. 3, doi. 10.1038/nm0112-3

By:

Venkataramanan, Madhumita

Publication type:

Article

Cutting out the middleman.

Published in:: 2009
Publication type:: Editorial

Cash injection for French biotechnology firms.

Published in:

Chemistry & Industry, 2009, n. 21, p. 5

By:

Todd, Stuart

Publication type:

Article

Buying big into biotech: scale, financing, and the industrial dynamics of UK biotech, 1980–2009.

Published in:

Industrial & Corporate Change, 2013, v. 22, n. 4, p. 903, doi. 10.1093/icc/dtt022

By:

Hopkins, Michael M.;
Crane, Philippa A.;
Nightingale, Paul;
Baden-Fuller, Charles

Publication type:

Article

Academic Hoaxes Have A Way Of Crystallizing, And Then Shattering, The Intellectual Pretensions Of An Era.

Published in:

Conflict Resolution & Negotiation Journal, 2014, v. 2014, n. 4, p. 60

By:

Atta-Eyison, Ebenezer

Publication type:

Article

DBT/MST should fund prudently.

Published in:

Current Science (00113891), 2016, v. 110, n. 12, p. 2210

By:

RAO, A. S.

Publication type:

Article

Avoiding premature licensing.

Published in:

Nature Reviews Drug Discovery, 2006, v. 5, n. 12, p. 985, doi. 10.1038/nrd2203

By:

Kessel, Mark;
Hall, Sam

Publication type:

Article

2009: Turning the corner.

Published in:

Nature Biotechnology, 2010, v. 28, n. 2, p. 116, doi. 10.1038/nbt0210-116

By:

Yang, Walter

Publication type:

Article

Still strapped for cash.

Published in:

Nature Biotechnology, 2009, v. 27, n. 6, p. 493, doi. 10.1038/nbt0609-493

By:

Huggett, Brady

Publication type:

Article

Corporate venture funds chase early-stage deals.

Published in:

Nature Biotechnology, 2009, v. 27, n. 5, p. 403, doi. 10.1038/nbt0509-403

By:

Mitchell, Peter

Publication type:

Article

Malaysia seeks biotech partners.

Published in:

Nature Biotechnology, 2009, v. 27, n. 4, p. 305, doi. 10.1038/nbt0409-305c

By:

Aldridge, Susan

Publication type:

Article

Bonsai biotech.

Published in:

2009

By:

Bains, William

Publication type:

Letter

Norway's swift bail out.

Published in:

Nature Biotechnology, 2009, v. 27, n. 3, p. 216, doi. 10.1038/nbt0309-216a

By:

Siva, Nayanah

Publication type:

Article

Venture capital shifts strategies, startups suffer.

Published in:

Nature Biotechnology, 2009, v. 27, n. 2, p. 103, doi. 10.1038/nbt0209-103

By:

Mitchell, Peter

Publication type:

Article

Biotech sector ponders potential 'bloodbath'.

Published in:

Nature Biotechnology, 2009, v. 27, n. 1, p. 3, doi. 10.1038/nbt0109-3

By:

Mitchell, Peter

Publication type:

Article

Public life cut short.

Published in:

Nature Biotechnology, 2009, v. 27, n. 1, p. 10, doi. 10.1038/nbt0109-10b

By:

Bethencourt, Victor

Publication type:

Article

Erratum: Where to float?

Published in:

2008

By:

Moran, Nuala

Publication type:

Correction Notice

India partners to fast track biotech.

Published in:

Nature Biotechnology, 2008, v. 26, n. 11, p. 1202, doi. 10.1038/nbt1108-1202

By:

Jayaraman, Killugudi

Publication type:

Article

Biotech resilient in Q3.

Published in:

Nature Biotechnology, 2008, v. 26, n. 11, p. 1212, doi. 10.1038/nbt1108-1212

By:

Lawrence, Stacy

Publication type:

Article

Aligning interests.

Published in:: Nature Biotechnology, 2008, v. 26, n. 11, p. 1199, doi. 10.1038/nbt1108-1199
Publication type:: Article

Q2 finance fall-off.

Published in:

Nature Biotechnology, 2008, v. 26, n. 8, p. 850, doi. 10.1038/nbt0808-850

By:

Lawrence, Stacy

Publication type:

Article

Pfizer jettisons Esperion.

Published in:

Nature Biotechnology, 2008, v. 26, n. 7, p. 724, doi. 10.1038/nbt0708-724

By:

Shaffer, Catherine

Publication type:

Article

Biotech slumps in Q1.

Published in:

Nature Biotechnology, 2008, v. 26, n. 5, p. 486, doi. 10.1038/nbt0508-486

By:

Lawrence, Stacy

Publication type:

Article

When less is more.

Published in:

Nature Biotechnology, 2007, v. 25, n. 8, p. 853, doi. 10.1038/nbt0807-853

By:

Booth, Bruce L

Publication type:

Article

A better prescription for drug-development financing.

Published in:

Nature Biotechnology, 2007, v. 25, n. 8, p. 859, doi. 10.1038/nbt0807-859

By:

Kessel, Mark;
Frank, Frederick

Publication type:

Article

Life support for life science innovation?

Published in:: Nature Biotechnology, 2007, v. 25, n. 2, p. 144, doi. 10.1038/nbt0207-144
Publication type:: Article

How the EU can fund your company.

Published in:: Nature Biotechnology, 2007, v. 25, n. 1, p. 21
Publication type:: Article

Danish biotech outperforms its European counterparts.

Published in:

Nature Biotechnology, 2006, v. 24, n. 12, p. 1460, doi. 10.1038/nbt1206-1460

By:

Moran, Nuala

Publication type:

Article

Pension plans dally with biotech.

Published in:

Nature Biotechnology, 2006, v. 24, n. 6, p. 600, doi. 10.1038/nbt0606-600

By:

Ransom, John

Publication type:

Article

Filters for preparing to meet a venture capitalist.

Published in:

Nature Biotechnology, 2003, v. 21, n. 7, p. BE49

By:

Christoffersen, Ralph

Publication type:

Article

Convincing a venture capitalist to invest in your idea.

Published in:

Nature Biotechnology, 2003, v. 21, n. 7, p. BE45

By:

Dooley III, Joseph F.;
Dooley Jr., Joseph F.

Publication type:

Article

Writing your business plan.

Published in:

Nature Biotechnology, 2002, v. 20, p. BE33, doi. 10.1038/nbt0602supp-BE33

By:

Cohen, Lorin

Publication type:

Article

In-licensing as a business model.

Published in:

Nature Biotechnology, 2002, v. 20, p. BE36, doi. 10.1038/nbt0602supp-BE36

By:

Schafer, Dennis P.

Publication type:

Article

Partnering challenges for startups.

Published in:

Nature Biotechnology, 2002, v. 20, p. BE40, doi. 10.1038/nbt0602supp-BE40

By:

French, J. Michael

Publication type:

Article

Integrating the intellectual property value chain.

Published in:

Nature Biotechnology, 2002, v. 20, p. BE43, doi. 10.1038/nbt0602supp-BE43

By:

Barrett, Bill;
Crawford, Dave

Publication type:

Article

Intellectual property as a foundation for funding.

Published in:

Nature Biotechnology, 2002, v. 20, p. BE47, doi. 10.1038/nbt0602supp-BE47

By:

Meltzer, Steven L.;
Marks, Michelle S.;
McCormick, James T.

Publication type:

Article

A counselor's dose of preventive medicine.

Published in:

Nature Biotechnology, 2002, v. 20, p. BE51, doi. 10.1038/nbt0602supp-BE51

By:

Redlick, David;
Kapner, Virginia

Publication type:

Article

Syndication?value in numbers.

Published in:

Nature Biotechnology, 2002, v. 20, p. BE54

By:

Sanborn, Killu Tougu

Publication type:

Article

Strategies for managing risk in equity.

Published in:

Nature Biotechnology, 2002, v. 20, p. BE57, doi. 10.1038/nbt0602supp-BE57

By:

Tang, C. Mark

Publication type:

Article

Initial public offerings, 1st quarter 2000.

Published in:: Nature Biotechnology, 2000, v. 18, n. 5, p. 476, doi. 10.1038/75258
Publication type:: Article

Biotech fundraising.

Published in:: Nature Biotechnology, 1999, v. 17, n. 8, p. 737, doi. 10.1038/11635
Publication type:: Article

Financing biotechnology in an inefficient market.

Published in:

Nature Biotechnology, 1999, v. 17, p. 31, doi. 10.1038/4640

By:

Purcell, Dennis J.

Publication type:

Article

Rational financing.

Published in:

Nature Biotechnology, 1999, v. 17, p. 33, doi. 10.1038/4641

By:

Birndorf, Howard C.

Publication type:

Article

Biotech finance: A family affair.

Published in:

Nature Biotechnology, 1999, v. 17, p. 35, doi. 10.1038/4643

By:

Hurwitz, Edward M.

Publication type:

Article

Stock market crash threatens start-up biotech companies.

Published in:

Nature, 1998, v. 395, n. 6698, p. 104, doi. 10.1038/25801

By:

Lehrman, Sally

Publication type:

Article